中药抑制肝癌侵袭与转移的研究进展Research Progress of Traditional Chinese Medicine in Inhibiting Invasion and Metastasis of Hepatocellular Carcinoma
戴美琴,李金州,陈娜娜,郭丹
DAI Meiqin,LI Jinzhou,CHEN Nana,GUO Dan
摘要(Abstract):
肝癌细胞的侵袭与转移是肝癌预后较差及易复发的主要原因,肝癌细胞的侵袭与转移包括一系列复杂的生物学变化。临床上西医采用的放、化疗联合方案易出现明显的毒副作用和耐药性且手术切除后转移发生率比较高,致使治疗效果不佳,而中药具有安全,毒副作用低,耐受性好,减少复发并延长患者生存期的优势。因此深入研究肝癌的侵袭与转移机制并从中药中寻找有效的抗肝癌侵袭与转移的药物具有重要意义。
Invasion and metastasis of hepatocellular carcinoma are the main causes of poor prognosis and recurrence in liver cancer,which include a series of complex biological changes.Current treatments had obvious side effects and drug resistance rates.The prognosis of patients with HCC after hepatectomy has been poor because of high incidences of recurrence and metastasis after treatments.The traditional Chinese medicine can reduce the recurrence and prolong patient's survival with low side effects and good tolerance.It is of great significance to study the mechanisms of invasion and metastasis and find effective traditional Chinese medicine for liver cancer.
关键词(KeyWords):
肝癌;中药;侵袭;转移
hepatocellular carcinoma;traditional Chinese medicine;invasion;metastasis
基金项目(Foundation): 广东省自然科学基金(2016A030313595);; 广州市科技计划项目(201707010074)
作者(Author):
戴美琴,李金州,陈娜娜,郭丹
DAI Meiqin,LI Jinzhou,CHEN Nana,GUO Dan
参考文献(References):
- [1]Feng M,Gao W,Wang R,et al.Therapeutically targeting glypican-3via a conformation-specific single-domain antibody in hepatocellular carcinoma[J].Proc Natl Acad Sci U S A,2013,110(12):1083-1091.
- [2]刘洋,李桂英,赵相轩,等.中药结合介入手段治疗肝癌的研究进展[J].临床肝胆病杂志,2015,31(1):118-122.
- [3]徐望,陈闯,郑燕怡,等.中医药关于原发性肝癌的研究进展[J].内蒙古中医药,2014,46(21):104-105.
- [4]王靖思,孙桂芝,赵杰.孙桂芝“益气活血软坚解毒法”论治原发性肝癌经验介绍[J].中华中医药杂志,2015,30(1):112-114.
- [5]王文成,王彬彬.吴良村应用“肝体阴而用阳”理论治疗原发性肝癌经验[J].辽宁中医杂志,2015,42(7):1195-1197.
- [6]Hsieh M,Lin C,Yang S,et al.Glabridin inhibits migration and invasion by transcriptional inhibition of matrix metalloproteinase 9through modulation of NF-B and AP-1 activity in human liver cancer cells[J].British Journal of Pharmacology,2014,171(12):3037-3050.
- [7]Hanahan D,Weinberg R A.Hallmarks of cancer:the next generation[J].Cell,2011,144(5):646-674.
- [8]Castellanos J A,Merchant N B,Nagathihalli N S.Emerging targets in pancreatic cancer:epithelial-mesenchymal transition and cancer stem cells[J].Oncotargets And Therapy,2013,6(13):1261-1267.
- [9]魏鹏辉,江一平,邓陈英.“见肝之病,知肝传脾,当先实脾”之实质[J].时珍国医国药,2015(11):2732-2733.
- [10]钟崇,李惠东,陈智远,等.健脾化瘀中药治疗肝癌临床研究[J].新中医,2013,45(12):129-132.
- [11]刘宏杰,李琦,韩植芬,等.补肾健脾方对裸鼠肝癌上皮-间质转化的影响[J].上海中医药大学学报,2015,29(3):53-56.
- [12]王丽芳,陈垦,臧林泉,等.黄连素对人肝癌细胞Hep G2上皮间质转化的影响及机制[J].广东医学,2014,35(12):1827-1829.
- [13]Wang Z,Wu Y,Wang Y,et al.Matrine inhibits the invasive properties of human glioma cells by regulating epithelialtomesenchymal transition[J].Mol Med Rep,2015,11(5):3682-3686.
- [14]Zhang Q,Li R,Zeng G,et al.Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression[J].World Journal of Gastroenterology,2014,20(29):10082-10093.
- [15]王金果,刘亚娴.甲乙煎影响H22小鼠肝癌组织黏附分子Ecadherin表达的实验研究[J].河北中医药学报,2009,24(1):5-6,15.
- [16]郭晨旭,吴迎春,朱元章,等.藏族药翼首草正丁醇部位提取物体外抑制人肝癌Hep3B细胞增殖和侵袭转移[J].中国实验方剂学杂志,2015,21(3):100-105.
- [17]Salimi S J,Manshaei M H,Sadeghi M.MMP-TIMP interactions in cancer invasion:An evolutionary game-theoretical framework[J].J Theor Biol,2017,412(7):17-26.
- [18]李俊立,丁月妮.二黄解郁汤对肝癌Hep G2细胞生长抑制及MMP-2表达的影响[J].湖北医药学院学报,2012,31(1):46-48.
- [19]王金全,陈启助,黄树林,等.黄芪总提取物促进PBMC对肝癌细胞的体外杀伤作用[J].广东药学院学报,2016,32(1):66-69.
- [20]贺武斌,苏荣健.白头翁皂苷D联合索拉非尼对人肝癌细胞转移的影响[J].天津医药,2016,54(7):302-305.
- [21]Liu J,Wen X,Liu B,et al.Diosmetin inhibits the metastasis of hepatocellular carcinoma cells by downregulating the expression levels of MMP-2 and MMP-9[J].Molecular Medicine Reports,2016,13(3):2401-2408.
- [22]Lin W,Zhong M,Liang S,et al.Emodin inhibits migration and invasion of MHCC-97H human hepatocellular carcinoma cells[J].Exp Ther Med,2016,12(5):3369-3374.
- [23]Hu Z,Dong N,Lu D,et al.A positive feedback loop between ROS and Mxi1-0 promotes hypoxia-induced VEGF expression in human hepatocellular carcinoma cells[J].Cell Signal,2017,31:79-86.
- [24]樊讯,成肇仁,李家庚,等.麝黄消瘤方对小鼠肝癌血管生成的抑制作用[J].中西医结合肝病杂志,2008,18(6):352-354.
- [25]李冰冰,唐德才,臧文华.补气活血类中药对血管内皮细胞增殖的影响[J].世界科学技术-中医药现代化,2014,16(3):572-577.
- [26]方瑜,杨柳青,陈光伟.扶正抗癌方对小鼠肝癌细胞转移影响的实验研究[J].陕西中医,2013,34(9):1253-1255.
- [27]赵锦燕,刘丽雅,万芸,等.熊胆粉对肝癌移植瘤裸鼠血管生成和细胞周期的影响[J].世界中西医结合杂志,2013,8(7):672-674,686.